This antibody portfolio includes a wide range of tissue- & tumor-specific primary antibodies for basic research, product development and analysis of a variety of biological questions. The monoclonal antibodies are perfectly applicable for all cell or tissue biology studies and for the analysis of predictive markers in research.
DCS-6 reacts specifically with cyclin D1 protein present predominantly in G1 phase of cell cycle; it does not cross-react with D2 or D3 cyclins (the closest relatives within the cyclin family); DCS-6 is especially useful in tumour diagnosis: it can be used as fast method to identify cases with 11q13 amplifications. Cyclin D1 gene is identical to the BCL-1 and the PRAD-1 oncogene and is part of the chromosome 11q13 amplicon which is amplified in several common tumour types like breast, lung, oesophagus, urinary bladder and head and neck carcinoma.
Polypeptide reacting: Mr 36 kDa polypeptide (cyclin D1 polypeptide of human cells).
Reactivity on cultured cell lines: MCF-7, MDA-MB-134 and MDA-MB-231 (breast cancer cell lines), UMSC22 (squamous cell carcinoma cell line), U-2-OS (osteosarcoma cell line), RT-112, A431, HT-29, 3T3-L1, Ins-1. The expression of Cyclin D1 is tissue specific and associated with tumour onset and progression.
Host: mouse
Antibody type: monoclonal
Isotype: IgG2a
Clone: DCS-6
Immunogen: human recombinant full-length cyclin D1 protein
UniprotID: Q64HP0 (dog, canis familiaris), P24385 (human), P25322 (mouse), P39948 (rat)
Synonym: G1/S-specific cyclin-D1, B-cell lymphoma 1 protein, BCL-1, BCL-1 oncogene, PRAD1 oncogene, CCND1, BCL1, PRAD1
Conjugate: unconjugated
Purification: affinity chromatography
Intended use: research use only
Application: ICC/IF, IHC, WB
Reactivity: dog, human, monkey, mouse, rat
Immunocytochemistry (ICC): Assay dependent
Immunohistochemistry (IHC) - frozen: 1:20-1:50 (2-5 μg/ml)
Immunohistochemistry (IHC) - paraffin: 1:20-1:50 (2-5 μg/ml, microwave treatment recommended)
Western Blot (WB): 1:50-1:100 (1-2 μg/ml)